Piccina Cintia
SEC-identified person · CIK 1907199 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Autolus Therapeutics plc AUTL | U.S. CCO & Country Gen Manager | filed 2026–2026 |
| Adaptimmune Therapeutics PLC ADAP] | Chief Commercial Officer | filed 2022–2025 |
| Kalaris Therapeutics, Inc. KLRS | Chief Commercial Officer | filed 2023–2023 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.